1.Experiment research of contrast-enhanced ultrasonography in diagnosis of pancreatic laceration
Qing SONG ; Yukun LUO ; Faqin Lü ; Ziyu JIAO ; Qiang LIU ; Tengfei YU ; Yuexiang WANG ; Jie TANG
Chinese Journal of Ultrasonography 2010;19(7):622-624
Objective To approach the diagnostic value of contrast-enhanced ultrasonography(CEUS)for the detection of traumatic laceration of pancreas. Methods Sixty cases of pancreatic traumatic model were made in twelve healthy swines after the animals were anesthetized and laparotomized. Then the conventional ultrasonography(US) and CEUS were performed in each case to diagnose the traumatic region,immediately. The results were compared with surgical findings. Results Among sixty injuries,the detection rate of conventional ultrasonography was 66. 7%,the detection rate of CEUS was 88.3%. Conclusions CEUS shows higher detection rate than conventional US in diagnosing pancreatic laceration,and it also can improve the diagnostic value of ultrasound for the detection of pancreatic laceration.
2.Haemostatic percutaneous injection therapy for renal trauma guided by contrast-enhanced ultrasonography
Zhiyan LI ; Jie TANG ; Faqin Lü ; Yukun LUO ; Tengfei YU ; Qing SONG ; Ziyu JIAO
Chinese Journal of Ultrasonography 2009;18(12):1053-1056
Objective To study haemostatic percutaneous injection therapy for the management of vascular damage in patients with renal injuries guided by contrast-enhanced ultrasonography(CEUS).Methods Which of 56 patients with renal trauma were diagnosis by CEUS,37 cases with grades Ⅱ-Ⅳ renal injuries were brought into our study.According to wound degree and accompanying active bleeding,they were divided into experiment group (percutaneous injection hemostatic treatment)and control group(conservative treatment).Results Thirty-seven renal trauma manifest low perfusion in lesions by CEUS,and the contrast agent could be seen overflow to renal pelvi and the location of capsule in 13 patients.The patients were divided into experiment group(17 cases)and control group(20 cases).The color of hematuria of 9 patients in experiment group became gradually light at 30 mins after treatment.and the color of 7 cases become normal,and hematuria of the only one was iterative appear.The color of hematuria of 9 patients in control group became gradually light in 24-72 hours,others' hematuria became gradually light in 5-14 days.The time of color of hematuria become light of the former was shorter than those of the latter(P<0.05).Reexamination by ultrasound and renal function and urine routine at 1,3 and 6 months after treatment,the results of all patients indicated normal.Conclusions Haemostatic percutaneous injection therapy for renal trauma guided by contrast-enhanced ultrasonography has very obvious hemostatic efficacy.Its advantages included may be used for effective,minimally invasive control of renal injuries(grades Ⅱ-Ⅳ),and can be a feasible management of active bleeding at bedside.
3.Combined haemostatic percutaneous injection therapy for renal trauma under guidance of contrast-enhanced ultrasonography
Zhiyan LI ; Jie TANG ; Yukun LUO ; Faqin Lü ; Ziyu JIAO ; Qing SONG ; Tengfei YU
Chinese Journal of Trauma 2010;26(8):739-742
Objective To study feasibility of combined haemostatic percutaneous injection therapy guided by contrast-enhanced ultrasonography (CEUS) in treatment of renal injuries. Methods Eighteen New Zealand rabbits were inflicted with kidney injury imitating grades Ⅲ-Ⅳ blunt injuries. The animals were randomly and equally divided into three groups, Group A ( treated with hemocoagulase),Group B ( treated with hemocoagulase and Alpha-cyanoacrylate) and Group C ( control group, given normal saline). The hemostatic time, hemostatic effect, and perirenal hematoma were observed. Results A perirenal hematoma was observed one hour after treatment. The perirenal fluid thickness was (0.200 ±0.012) cm in Group A, (0.050 ±0.002) cm in Group B and (0.400 ±0.009) cm in Group C, with statistical significance between two test groups and Group C (P < 0.05 ). At days 7 and 14 following treatment, lesion length and cross section was ( 1. 107 ±0. 143) cm and (0.433 ±0. 163) cm in Group A, (0.567 ±0.082) cm and (0. 160 ±0. 078) cm in Group B, and (0.980 ±0. 203) cm and (0.686 ± 0. 157) cm in Group C. There was statistical significance between the test groups (Groups A and B) and Group C (P<0. 01) at day 14. The lesion size in Group A was lager than that in Group B (P < 0.01 ). One month after treatment, a slight nephrohydrosis occurred in Group B. Conclusions Either injection of simple hemocoagulase or combined use of hemocoagulase and Alpha-cyanoacrylate guided by CEUS can attain positive hemostatic effect, but the latter one is more rapid and reliable.
4.Determination of Uric Acid Based on Active Copper-Containing Carbon Nanodots-modified Electrochemical Biosensor
Hongying LIU ; Tengfei JIN ; Daxiang DAI ; Mingru JIAO ; Cheng HUANG ; Mingzhen ZHANG ; Chunchuan GU
Chinese Journal of Analytical Chemistry 2017;45(8):1103-1108
The active copper-containing carbon nanodots were prepared by hydrothermal method, and then characterized by fluorescence spectroscopy and UV-visible absorption spectroscopy.Subsequently, a highly sensitive and selective electrochemical biosensor was fabricated on the basis of this synthesized carbon nanodots with electro-deposition technique.The electrode behavior was investigated by cyclic voltammetry, electrochemical impedance spectroscopy, and differential pulse voltammetry.Furthermore, the catalysis mechanism was studied.The experimental results indicated that the biosensor exhibited a strong electrocatalytic activity toward the oxidation of uric acid (UA).What′s more, the interference from ascorbic acid and dopamine was eliminated effectively.Under the optimum conditions, there were linear relationships between the anodic peak current and the concentration of UA (1.00-300.0 μmol/L), and the limit detection was 0.30 μmol/L (S/N=3).The prepared biosensor had advantages such as easy fabrication, strong anti-interference ability, high sensitivity, and wide detection range, and could be used for real sample detection.
5. Role of UBE2T gene in the migration and invasion of hepatocellular carcinoma cells and its clinical significance
Tumor 2018;38(5):408-418
Objective: To investigate the expression and clinical significances of ubiquitin conjugating enzyme E2 T (UBE2T) in hepatocellular carcinoma (HCC), and explore the role of UBE2T gene expression in migration and invasion of HCC cells. Methods: The expression of UBE2T mRNA in 54 pairs of HCC tissues and the matched noncancerous liver tissues was analyzed by real-time fluorescent quantitative PCR. The expression level of UBE2T protein in 233 cases of HCC tissues was detected by immunohistochemistry, then the relationship between UBE2T expression and clinicopathological features of HCC patients was analyzed. The recombinant lentiviral vector pWPXL-UBE2T contained UBE2T gene sequences was constructed and further transfected into Hep3B and SMMC-7721 cells. In the other hand, the recombinant lentiviral vector GV248-shUBE2T-1 and GV248-shUBE2T-2 targeted UBE2T gene were transfected into MHCC-LM3 and SK-Hep1 cells. The forced expression and knockdown of UBE2T gene were validated by real-time fluorescent quantitative PCR and Western blotting. Afterwards, the effects of UBE2T gene overexpression and silencing on migratory and invasive abilities of HCC cells were detected by Transwell chamber assays, respectively. Results: The UBE2T mRNA level in HCC tissues was significantly higher than that in the matched noncancerous liver tissues (P < 0.000 1). The expression of UBE2T protein was correlated with intrahepatic metastasis of HCC (P = 0.004) in 233 patients with HCC. Compared with the control group, the forced expression of UBE2T gene markedly promoted both migration and invasion of Hep3B and SMMC-7721 cells (both P < 0.01); while the knockdown of UBE2T gene obviously inhibited the migration and invasion of MHCC-LM3 and SK-Hep1 cells as compared with the negative control group (both P < 0.05). Conclusion: High expression level of UBE2T in HCC tissues is correlated with the presence of intrahepatic metastasis, and the overexpression of UBE2T gene can promote the migration and invasion of HCC cells.
6.Design & development of the stroke rehabilitation evaluation system.
Chinese Journal of Medical Instrumentation 2013;37(5):333-335
The stroke rehabilitation evaluation system has been designed and developed in view of the present practice status of clinical rehabilitation medicine. The system not only implements patient information collection and rehabilitation evaluation, but also outputs individual rehabilitation program automatically according to evaluation outcome.
Humans
;
Outcome Assessment (Health Care)
;
methods
;
Software Design
;
Stroke Rehabilitation
7.Research advances in MEF2D in neurological disorders
Tengfei JIAO ; Abudusalamu RENA ; Dengfeng HAN
Journal of Apoplexy and Nervous Diseases 2025;42(3):279-283
Neurological disorders are an important cause of global human disease burden, but the mechanisms of the development and progression of neurological disorders remain unclear, and most studies have shown that they are associated with the expression of mutations in human genes. MEF2D, as an important transcription factor in the MEF2 family, plays an important role in both physiological and pathological processes. Related studies have found that MEF2D can be involved in neuronal survival, regulate neuronal responses to stimuli, and participate in the pathogenic process of neurological disorders. This article reviews the research advances in MEF2D in common neurological disorders.
8. Clinicopathological features, diagnosis and treatment of primary and metastatic hepatic neuroendocrine neoplasm originating from digestive tract
Xiaoxiao JIAO ; Zhaodi WANG ; Tengfei ZHANG ; Lianfeng ZHANG ; Wang MA ; Lin ZHOU
Chinese Journal of Digestion 2019;39(11):752-758
Objective:
To explore the clinicopathological characteristics of primary hepatic neuroendocrine neoplasm (HNEN) and metastatic HNEN from digestive tract, to screen the risk factors of hepatic metastasis of gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) and to analyze the differences between primary and metastatic HNEN in clinical features, diagnosis, treatment and prognosis.
Methods:
From January 2010 to June 2017, the clinical data of 182 patients with HNEN admitted at The First Affiliated Hospital of Zhengzhou University were retrospectively analyzed, including 39 cases of primary HNEN, 129 cases of metastatic HNEN and 14 cases of HNEN with unknown primary lesions. Chi-square test and
9.Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.
Yun TAN ; Feng LIU ; Xiaoguang XU ; Yun LING ; Weijin HUANG ; Zhaoqin ZHU ; Mingquan GUO ; Yixiao LIN ; Ziyu FU ; Dongguo LIANG ; Tengfei ZHANG ; Jian FAN ; Miao XU ; Hongzhou LU ; Saijuan CHEN
Frontiers of Medicine 2020;14(6):746-751
The ongoing pandemic of Coronavirus disease 19 (COVID-19) is caused by a newly discovered β Coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How long the adaptive immunity triggered by SARS-CoV-2 can last is of critical clinical relevance in assessing the probability of second infection and efficacy of vaccination. Here we examined, using ELISA, the IgG antibodies in serum specimens collected from 17 COVID-19 patients at 6-7 months after diagnosis and the results were compared to those from cases investigated 2 weeks to 2 months post-infection. All samples were positive for IgGs against the S- and N-proteins of SARS-CoV-2. Notably, 14 samples available at 6-7 months post-infection all showed significant neutralizing activities in a pseudovirus assay, with no difference in blocking the cell-entry of the 614D and 614G variants of SARS-CoV-2. Furthermore, in 10 blood samples from cases at 6-7 months post-infection used for memory T-cell tests, we found that interferon γ-producing CD4
Adaptive Immunity/physiology*
;
Adult
;
Aged
;
Antibodies, Neutralizing/blood*
;
COVID-19/immunology*
;
Cohort Studies
;
Female
;
Humans
;
Immunoglobulin G/blood*
;
Male
;
Middle Aged
;
SARS-CoV-2/immunology*
;
T-Lymphocytes/physiology*
;
Time Factors
;
Viral Proteins/immunology*
10.ISA 61 VG adjuvant enhances protective immune response of Listeria monocytogenes inactivated vaccine.
Tengfei ZHU ; Fanzeng MENG ; Hao YAO ; Yuting WANG ; Xin'an JIAO ; Yuelan YIN
Chinese Journal of Biotechnology 2020;36(7):1378-1385
Listeria monocytogenes (Lm) is zoonotic pathogen that can cause listeriosis, and vaccine is one of the effective methods to prevent this pathogen infection. In this study, we developed a novel vaccine that is a mixture of inactivated bacteria and Montanide™ ISA 61 VG, a mineral oil adjuvant, and evaluated the safety and immune response characteristics of this vaccine. The mice immunized with the ISA 61 VG adjuvant had high safety, and it could induce significantly higher titer of anti-listeriolysin O (LLO) antibody and higher value of IgG2a/IgG1 ratio compared with the group without the adjuvant. In particular, it could provide 100% immune protection against lethal doses of Lm challenge in mice. In summary, ISA 61VG adjuvant significantly enhanced the ability of inactivated listeria vaccine to induce humoral and cellular immune responses, thereby enhanced the protective immune response in the host, and it is a potential vaccine candidate for the prevention of Lm infection in humans and animals.
Adjuvants, Immunologic
;
pharmacology
;
Animals
;
Hemolysin Proteins
;
immunology
;
pharmacology
;
Immunity, Cellular
;
drug effects
;
Listeria monocytogenes
;
immunology
;
Listeriosis
;
prevention & control
;
Mice
;
Mice, Inbred BALB C
;
Vaccines, Inactivated
;
immunology